Class REMS For Botulinum Toxin Products Warns Against Interchangeabilty
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA announced a class-wide REMS for botulinum toxin products that focuses on the dangers on interchangeability of the drugs.